AstroSafe I with AstroScan

Product Overview
  • Science-based, in situ filter testing validates field system integrity and provides visual indication of potential issues and rapid reverification following an exposure event.
  • Multiple, overlapping sampling probes enable uniform entry and provide highly accurate leak diagnostics and filter treatment functionality.
  • Actuator assemblies do not penetrate the containment barrier, and all critical maintenance, including driver assembly replacement, can be completed without entering the
  • containment housing.
  • Upgrade options include automatic drivers, reconfiguration, and the addition of new technology.

In the dynamic fields of microbiological and biomedical research, mutating pathogens and rapid scientific and technological advancements are increasing and elevating inherent risks, highlighting the need for innovations in biosafety.

In the dynamic fields of microbiological and biomedical research, mutating pathogens and rapid scientific and technological advancements are increasing and elevating inherent risks, highlighting the need for innovations in biosafety.

  • The emergence and spread of rapidly mutating, virulent organisms
  • The genetic modification of organisms to enhance outcomes
  • The location of research facilities with high-level biosecurity requirements in densely populated areas
  • Rapid human mobility
  • Increasingly stringent regulatory requirements
  • The need to address the public’s perceptions of risk with science-based solutions

Science-based, verifiable risk mitigation keeps people safe and enables critical, life-saving research to continue unimpeded.

Risk mitigation begins with identification and analysis.

  • Every facility is unique in terms of protocol, which changes over time
  • Every process implemented must be analyzed to identify inherent risks
  • Each risk must be evaluated in terms of probability of occurrence and potential consequences, and an acceptable level of risk must be determined
  • Once controls are applied, residual risk must be assessed

Once applied, controls must be continually and consistently evaluated to verify the determined level of risk mitigation. Core technology specific risk assessments are key to determining if legacy technologies remain sufficient considering emerging technology and conditions.

  • Science-based, in situ filter testing validates field system integrity and provides visual indication of potential issues and rapid reverification following an exposure event.
  • Multiple, overlapping sampling probes enable uniform entry and provide highly accurate leak diagnostics and filter treatment functionality.
  • Actuator assemblies do not penetrate the containment barrier, and all critical maintenance, including driver assembly replacement, can be completed without entering the containment housing.
  • Upgrade options include automatic drivers, reconfiguration, and the addition of new technology.
  • Healthcare
  • Food & Beverage
  • Pharmaceutical
  • Biotechnology